NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-135-2025-0-US-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE US 63/501,497 Expired
NCI E-126-2022-0-PC-01 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 PCT PCT PCT/US2023/066839 Expired
NHLBI E-197-2020-0-US-02 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING US National Stage 18/036,392 Pending
NHLBI E-197-2020-0-IL-01 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING IL National Stage 302823 Pending
NICHD E-010-2021-0-US-02 ENHANCED ANTIGEN REACTIVITY OF IMMUNE CELLS EXPRESSING A MUTANT NON-SIGNALING CD3 ZETA CHAIN US National Stage 18/036,112 Pending
NIAID E-066-2014-0-US-02 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US DIV 18/314,052 11969466 Issued PDF
NCI E-231-2020-0-JP-01 METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY JP National Stage 2023-550709 Pending
NICHD E-115-2022-0-PK-01 NESTORONE® / TESTOSTERONE TRANSDERMAL GEL PK ORD 272/2023 Pending
NICHD E-115-2022-0-BD-01 NESTORONE® / TESTOSTERONE TRANSDERMAL GEL BD ORD 125/2023 Pending
NICHD E-115-2022-0-PCT-02 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL PCT PCT PCT/US2023/021154 Expired
NHLBI E-061-2022-0-PC-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING PCT PCT PCT/US2023/021238 Expired
NINDS E-130-2022-3-CN-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE CN DIV 202310498623.5 Pending
NCI E-167-2019-0-CN-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY CN National Stage 202180074998.8 Pending
NIAID E-109-2023-0-US-01 NEUTRALIZING ANTIBODIES TO DENGUE VIRUS E PROTEIN AND THEIR USE US 63/464,370 Expired
NHLBI E-119-2022-0-PC-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE PCT PCT PCT/US2023/066617 Expired
NCI E-231-2020-0-US-01 METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY US National Stage 18/251,751 Pending
NCI E-060-2021-0-US-02 ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF US National Stage 18/035,427 Pending
NHLBI E-005-2021-0-US-02 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE US National Stage 18/035,240 Pending
NCI E-068-2018-0-US-02 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 US CON 18/310,744 12157762 Issued PDF
NCI E-048-2022-0-PC-01 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS PCT PCT PCT/US2023/066487 Expired
NIDDK E-138-2017-0-AU-01 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS AU DIV 2023202694 Pending
NCI E-265-2015-0-US-02 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS US CON 18/310,141 Pending
NIEHS E-164-2023-0-US-01 APOE-ACTIVATING NONCODING RNA (eRNA) AND USES THEREOF US 63/463,165 Expired
NHGRI E-134-2023-0-US-01 SYNTHETIC MMAB GENES AND AAV VECTORS TO TREAT COBALAMIN B DEFICIENCY US 63/499,013 Expired
NCI E-189-2020-1-AU-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION AU National Stage 2021351710 Pending
NCI E-189-2020-1-KR-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION KR National Stage 10-2023-7014854 Pending
NCI E-150-2020-0-US-02 Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome US National Stage 18/250,816 Pending
NINDS E-113-2022-1-PCT-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 PCT PCT PCT/US2023/066224 Expired
NIBIB E-118-2022-0-PC-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER PCT PCT PCT/US2023/020026 Expired
NCI E-253-2020-0-US-02 SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF US National Stage 18/033,656 Pending
NIAID E-001-2017-1-EP-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION EP DIV 23169546.1 Pending
NIAID E-064-2016-1-IN-02 A RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) F ECTODOMAIN TRIMER IN DIV 202318029450 Pending
NIAID E-064-2016-1-IN-01 A RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) F ECTODOMAIN TRIMER IN DIV 202318029501 Pending
NCI E-189-2020-1-CN-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION CN National Stage 202180072524.X Pending
NIDCR E-196-2021-0-PC-01 LENS ARRAY BASED IMAGING SYSTEM WITH IMPROVED FIELD OF VIEW PCT PCT PCT/US2023/019360 Expired
NIDCR E-130-2023-0-US-01 Treatment of Postsurgical Hypoparathyroidism by UsingTriphenyl Calcilytic Compounds US 63/497,693 Expired
NCI E-173-2020-0-CN-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 CN National Stage 202180071809.1 Pending
NIAID E-004-2022-0-AU-01 STAR POLYMER DRUG CONJUGATES AU National Stage 2021364709 Pending
NCI E-143-2023-0-US-01 Repurposing Shingrix and Gardasil Immunity in Combination with a Tumor Associated Antigen US 63/497,348 Expired
NCI E-211-2020-0-EP-01 PLK1 POLO DOMAIN INHIBITORS AND METHOD OF TREATING CANCER EP National Stage 21795110.2 Pending
NIDA E-199-2015-0-US-03 Method and Apparatus for the Capture of Intra-cellular Activity US CON 18/135,738 12268512 Issued PDF
NCI E-211-2020-0-AU-01 PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER AU National Stage 2021350736 Pending
NIAID E-168-2020-2-HK-01 Corona Virus Binders HK EP 62023071524.0 Pending
NCI E-189-2020-1-GB-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION GB National Stage 2305617.9 Abandoned
NIDCR E-107-2022-1-NZ-01 TRIPHENYL CALCILYTIC COMPOUNDS FOR THE TREATMENT OF AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) NZ National Stage 799089 Pending
NIAID E-090-2021-0-PC-01 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use PCT PCT PCT/US2023/065775 Expired
NHGRI E-147-2020-0-US-03 HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXOCOBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS US National Stage 18/032,132 Pending
NIDCD E-043-2016-0-US-02 MICRORNAS AND METHODS OF THEIR USE US DIV 18/301,040 Abandoned
NIBIB E-007-2021-0-US-02 ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS US National Stage 18/031,814 Abandoned
NCI E-107-2020-0-CN-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS CN National Stage 202180070402.7 Pending